Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies Georg Schett, known for CAR-T work, moves in a new direction

https://www.statnews.com/2026/08/12/boulevard-bio-georg-schett-antibody-therapies/ By Allison DeAngelisAug. 12, 2026 Biotech Startups and Venture Capital Reporter